Hansoh Pharmaceutical Group Co (HKSE:03692) EV-to-EBITDA : 18.64 (As of May. 04, 2024)

Hansoh Pharmaceutical Group Co EV-to-EBITDA Chart

Hansoh Pharmaceutical Group Co Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBITDA	Get a 7-Day Free Trial									21.15	-	18.33	-	15.43

Competitive Comparison of Hansoh Pharmaceutical Group Co's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Hansoh Pharmaceutical Group Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hansoh Pharmaceutical Group Co's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hansoh Pharmaceutical Group Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Hansoh Pharmaceutical Group Co's EV-to-EBITDA falls into.

Hansoh Pharmaceutical Group Co EV-to-EBITDA Calculation

Hansoh Pharmaceutical Group Co's EV-to-EBITDA for today is calculated as:

Hansoh Pharmaceutical Group Co's current Enterprise Value is HK$85,607 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Hansoh Pharmaceutical Group Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$4,593 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hansoh Pharmaceutical Group Co  (HKSE:03692) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Hansoh Pharmaceutical Group Co's PE Ratio for today is calculated as:

Hansoh Pharmaceutical Group Co's share price for today is HK$18.24.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Hansoh Pharmaceutical Group Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.569.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Hansoh Pharmaceutical Group Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Hansoh Pharmaceutical Group Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Hansoh Pharmaceutical Group Co (HKSE:03692) Business Description